Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 28 Jul 2023

Identification of non-small cell lung cancer with chronic obstructive pulmonary disease using clinical symptoms and routine examination: a retrospective study

in Thoracic Oncology

Bing Zhuan
Hong-Hong Ma
Bo-Chao Zhang
Ping Li
Xi Wang
Qun Yuan
Zhao Yang
Jun Xie

Frontiers in Oncology

doi 10.3389/fonc.2023.1158948

2,989 views

Original Research

Published on 27 Jul 2023

Common nutritional/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy

in Thoracic Oncology

Huohuan Tian
Guo Li
Wang Hou
Jing Jin
Chengdi Wang
Pengwei Ren
Haoyu Wang
Jie Wang
Weimin Li
Dan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211752

3,613 views
8 citations

Systematic Review

Published on 26 Jul 2023

Clinical utility and diagnostic value of tumor-educated platelets in lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Elvan Wiyarta
Darrin Ananda Nugraha
Muhammad Indera Ramadani
Gita Fajri Gustya
Muhammad Farrasy Ammar
Hana Dzakira Edwar
Nildza Kheirizzad
Mutiah Nurul Mukhlisah
Erlina Burhan
Elisna Syahruddin

Frontiers in Oncology

doi 10.3389/fonc.2023.1201713

4,414 views
4 citations

Case Report

Published on 24 Jul 2023

Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report

in Thoracic Oncology

Jiantao Wang
Wenqing Yao
Weiya Wang
Mingyu Fan
Kaili Huang
Zhenkun Liu
Daxing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1164543

3,036 views
3 citations

Review

Published on 21 Jul 2023

Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients

in Thoracic Oncology

Justyna Raczkowska
Agnieszka Bielska
Adam Krętowski
Magdalena Niemira

Frontiers in Oncology

doi 10.3389/fonc.2023.1209299

4,462 views
15 citations

Original Research

Published on 20 Jul 2023

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study

in Thoracic Oncology

Marion Tonneau
Kim Phan
Venkata S. K. Manem
Cecile Low-Kam
Francis Dutil
Suzanne Kazandjian
Davy Vanderweyen
Justin Panasci
Julie Malo
François Coulombe

Frontiers in Oncology

doi 10.3389/fonc.2023.1196414

5,597 views
11 citations

Original Research

Published on 20 Jul 2023

Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study

in Thoracic Oncology

Guotian Pei
Dawei Wang
Kunkun Sun
Yingshun Yang
Wen Tang
Yanfeng Sun
Siyuan Yin
Qiang Liu
Shuai Wang
Yuqing Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1224455

3,169 views
7 citations

Case Report

Published on 13 Jul 2023

The tumor or inflammation? a case report on primary pulmonary choriocarcinoma

in Thoracic Oncology

Na Wang
Nan Zhang
Xinyue Zhang
Yuanyuan Wang
Yajie Fu
Lingfei Guo
Changhu Liang
Mengru Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1108798

2,049 views
1 citation

Original Research

Published on 12 Jul 2023

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

in Thoracic Oncology

Qiyu Fang
Xiaoying Wan
Angelica D’Aiello
Hui Sun
Weiquing Gu
Yixue Li
Caicun Zhou
Boxiong Xie
Qinfang Deng
Haiying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1116809

2,874 views
6 citations

Original Research

Published on 12 Jul 2023

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence

in Thoracic Oncology

Angela Davey
Maria Thor
Marcel van Herk
Corinne Faivre-Finn
Andreas Rimner
Joseph O. Deasy
Alan McWilliam

Frontiers in Oncology

doi 10.3389/fonc.2023.1156389

2,563 views
3 citations

Case Report

Published on 10 Jul 2023

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity

in Thoracic Oncology

Nicoletta Staropoli
Angela Salvino
Federica Falcone
Valentina Farenza
Martina Costa
Giacomo Rossini
Francesco Manti
Antonella Crispino
Caterina Riillo
Domenico Ciliberto

Frontiers in Oncology

doi 10.3389/fonc.2023.1145986

5,686 views
4 citations

Case Report

Published on 10 Jul 2023

Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion–positive non–small cell lung cancer: a case report

in Thoracic Oncology

Daniela Scattolin
Elena Scagliori
Antonio Scapinello
Alberto Fantin
Valentina Guarneri
Giulia Pasello

Frontiers in Oncology

doi 10.3389/fonc.2023.1201599

3,276 views
5 citations

Systematic Review

Published on 06 Jul 2023

Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Peiling Cai
Bofan Yang
Jiahui Zhao
Peng Ye
Dongmei Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1207892

3,049 views
3 citations

Case Report

Published on 05 Jul 2023

Lung adenocarcinoma with bladder metastasis: A case report and literature review

in Thoracic Oncology

Yuying Liu
Xinyue Dong
Tao Li
Yanke Xing
Na Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1202885

6,322 views
3 citations

Clinical Trial

Published on 05 Jul 2023

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

in Thoracic Oncology

Christian Wilhelm Langberg
Henrik Horndalsveen
Åslaug Helland
Vilde Drageset Haakensen

Frontiers in Oncology

doi 10.3389/fonc.2023.1217424

3,199 views
3 citations

Original Research

Published on 05 Jul 2023

Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis

in Thoracic Oncology

Huaikai Shi
Le Zhang
Ta-Kun Yu
Ling Zhuang
Helen Ke
Ben Johnson
Emma Rath
Kenneth Lee
Sonja Klebe
Steven Kao

Frontiers in Oncology

doi 10.3389/fonc.2023.1162027

4,004 views
4 citations

Original Research

Published on 05 Jul 2023

Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study

in Thoracic Oncology

Helen Brooks
Ling Li
Alfredo Addeo
Megan Stevens
Charles Comins
Sebastian Oltean

Frontiers in Oncology

doi 10.3389/fonc.2023.1197037

2,054 views

Original Research

Published on 05 Jul 2023

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape

in Thoracic Oncology

Lingjun Dong
Linhai Fu
Ting Zhu
Yuanlin Wu
Zhupeng Li
Jianyi Ding
Jiandong Zhang
Xiang Wang
Junjun Zhao
Guangmao Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1180723

5,525 views
8 citations

Original Research

Published on 04 Jul 2023

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience

in Thoracic Oncology

Paolo Borghetti
Giulia Volpi
Giorgio Facheris
Gianluca Cossali
Eneida Mataj
Salvatore La Mattina
Navdeep Singh
Jessica Imbrescia
Marco Lorenzo Bonù
Davide Tomasini

Frontiers in Oncology

doi 10.3389/fonc.2023.1208204

5,539 views
8 citations

Original Research

Published on 04 Jul 2023

Camrelizumab as a novel third or post-third-line treatment strategy in small cell lung cancer: a retrospective study of 12 patients

in Thoracic Oncology

Jizheng Tian
Lili Sui
Hong Wang
Xiaoyan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1180735

2,417 views
3 citations

Case Report

Published on 03 Jul 2023

Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report

in Thoracic Oncology

Aurélie Louvet
Natasha Honoré
Anne-France Dekairelle
Cédric Van Marcke
Jean-Charles Goeminne

Frontiers in Oncology

doi 10.3389/fonc.2023.1143775

2,766 views

Original Research

Published on 30 Jun 2023

A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses

in Thoracic Oncology

Wenlong Zhang
Chuzhong Wei
Fengyu Huang
Wencheng Huang
Xiaoxin Xu
Xiao Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1104137

4,290 views
12 citations

Case Report

Published on 28 Jun 2023

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports

in Thoracic Oncology

Lionel Michaux
Alexandre Perrier
Camille Mehlman
Hussa Alshehhi
Antonin Dubois
Roger Lacave
Florence Coulet
Jacques Cadranel
Vincent Fallet

Frontiers in Oncology

doi 10.3389/fonc.2023.1182558

3,916 views
6 citations

Original Research

Published on 27 Jun 2023

RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC

in Thoracic Oncology

Qian Wang
Tao Yu
Zi-Hao Ke
Fu-Feng Wang
Jia-Ni Yin
Yang Shao
Kai-Hua Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1172728

4,812 views
5 citations

1,929 articles

articles

Identification of non-small cell lung cancer with chronic obstructive pulmonary disease using clinical symptoms and routine examination: a retrospective study

Common nutritional/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy

Clinical utility and diagnostic value of tumor-educated platelets in lung cancer: a systematic review and meta-analysis

Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report

Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study

Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study

The tumor or inflammation? a case report on primary pulmonary choriocarcinoma

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity

Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion–positive non–small cell lung cancer: a case report

Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis

Lung adenocarcinoma with bladder metastasis: A case report and literature review

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis

Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience

Camrelizumab as a novel third or post-third-line treatment strategy in small cell lung cancer: a retrospective study of 12 patients

Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report

A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports

RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC